Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentManas Chakraborty, Kunal Dhiman, Veer Gupta
Cellular and Molecular Life Sciences : CMLS|February 17, 2019
Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesisKunal Dhiman, Kaj Blennow, Henrik Zetterberg, et al.
Cellular and Molecular Life Sciences : CMLS|March 4, 2022
Neuroserpin, a crucial regulator for axogenesis, synaptic modelling and cell-cell interactions in the pathophysiology of neurological diseaseAngela Godinez, Rashi Rajput, Nitin Chitranshi, et al.
Neuroscience Letters|May 26, 2020
Decreased cerebrospinal fluid neuronal pentraxin receptor is associated with PET-Aβ load and cerebrospinal fluid Aβ in a pilot study of Alzheimer's diseaseBryant Lim, Christopher Fowler, Qiao-Xin Li, et al.
Aging and Disease|December 9, 2021
Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer's DiseaseMorteza Abyadeh, Vivek Gupta, Veer Gupta, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 8, 2022
Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individualsKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
Biomedicines|May 28, 2022
Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal StudyKunal Dhiman, Victor L Villemagne, Christopher Fowler, et al.
The Australian and New Zealand Journal of Psychiatry|June 22, 2019
A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?Dhamidhu Eratne, Samantha M Loi, Nirbaanjot Walia, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 27, 2020
Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's diseaseKunal Dhiman, Veer Bala Gupta, Victor L Villemagne, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2022
Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settingsDhamidhu Eratne, Samantha M Loi, Qiao-Xin Li, et al.
Pageof 1